マーシャル 祥子
   Department   School of Medicine(Tokyo Women's Medical University Adachi Medical Center), School of Medicine
   Position   Assistant Professor
Article types Original article
Language English
Peer review Peer reviewed
Title A comparison of weekly paclitaxel and cetuximab with the EXTREME regimen in the treatment of recurrent/metastatic squamous cell head and neck carcinoma.
Journal Formal name:Oral oncology
Abbreviation:Oral Oncol
ISSN code:(1879-0593)1368-8375(Linking)
Domestic / ForeginForegin
Volume, Issue, Page 73,pp.21-26
Author and coauthor Nakano Kenji†, Marshall Shoko, Taira Shinichiro, Sato Yukiko, Tomomatsu Junichi, Sasaki Toru, Shimbashi Wataru, Fukushima Hirofumi, Yonekawa Hiroyuki, Mitani Hiroki, Kawabata Kazuyoshi, Takahashi Shunji
Authorship 2nd author
Publication date 2017/10
Summary In selected R/M SCCHN patients, the combination of weekly paclitaxel and cetuximab could be the better treatment option than the EXTREME regimen.
DOI 10.1016/j.oraloncology.2017.07.022
PMID 28939072